Vascular endothelial growth factor in coronary sinus: Evidence for its association with coronary collaterals

Scandinavian Cardiovascular Journal

Volumn 39, Issue 6, 2005, Pages 353-357

  Lin, Tsung Hsien ^a   Yen, Hsueh Wei ^a   Voon, Wen Chol ^a   Su, Ho Ming ^a   Lu, Ye Hsu ^a   Lai, Wen Ter ^a   Sheu, Sheng Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Coronary artery disease; Coronary collaterals; Coronary sinus; Transforming growth factor; Vascular endothelial growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY SINUS BLOOD FLOW; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART CATHETERIZATION; HEART RIGHT ATRIUM; HEPARINIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; PATIENT SCHEDULING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION;

COLLATERAL CIRCULATION; CORONARY ARTERIOSCLEROSIS; CORONARY STENOSIS; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 27844496243     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430500234258     Document Type: Article

References (20)

1. Pepper, MS. (1997) Manipulating angiogenesis: From basic science to the bedside Arterioscler Thromb Vasc Biol, 17, pp. 605-19.
2. Henry, TD. (1999) Therapeutic angiogenesis Br Med J, 318, pp. 1536-9.
3. Henry, TD and Annex, BH and McKendall, GR and Azrin, MA and Lopez, JJ and Gjordano, FJ and (2003) VIVA Investigators. The VIVA trial: Vascular Endothelial Growth Factor in ischemia for vascular angiogenesis Circulation, 107, pp. 1359-65.
4. Pepper, MS. (1997) Transforming growth factor-ß: Vasculogenesis, angiogenesis, and vessel wall integrity Cytokine Growth Factor Rev, 8, pp. 21-43.
5. Zheng, W and Seftor, EA and Meininger, CJ and Hendrix, MJ and Tomanek, RJ. (2001) Mechanisms of coronary angiogenesis in response to stretch, role of VEGF and TGF-beta Am J Physiol Heart Circ Physiol, 280, pp. H909-17.
6. Cohen, M and Rentrop, KP. (1986) Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: A prospective study Circulation, 74, pp. 469-76.
7. Kawamoto, A and Kawata, H and Akai, Y and Katsuyama, Y and Takase, E and Sasaki, Y and (1998) Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction Int J Cardiol, 67, pp. 47-54.
8. East, MA and Landis, DI and Thompson, MA and Annex, BH. (2003) Effect of single dose of intravenous heparin on plasma levels on angiogenic growth factors Am J Cardiol, 91, pp. 1234-6.
9. Piek, JJ and Koolen, JJ and Hoedemaker, G and David, GK and Visser, CA and Dunning, AJ. (1991) Severity of single-vessel coronary arterial stenosis and duration of angina as determinants of recruitable collateral vessels during balloon angioplasty occlusion Am J Cardiol, 67, pp. 13-7.
10. David A. Engler. Use of vascular endothelial growth factor for therapeutic angiogenesis. Circulation 1996;94:1496-8.
11. Losordo, DW and Vale, PR and Symes, JF and Dunnington, CH and Esakof, DD and Maysky, M and (1998) Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF 165 as sole therapy for myocardial ischaemia Circulation, 98, pp. 2800-4.
12. Aylit Schultz, Lena Lavie, Irit Hochberg. Inter individual heterogeneity in the hypoxic regulation of VEGF. Circulation 1999;100:547-52.
13. Hojo, Y and Ikeda, U and Zhu, Y and Okada, M and Lieno, S and Arakawa, H and (2000) Expression of vascular endothelial growth factor in patients with acute myocardial infarction J Am Coll Cardiol, 35, pp. 968-73.
14. Seko, Y and Imai, Y and Suzuki, S and Kamijukkoku, S and Hayasaki, K and Sakomura, Y and (1997) Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy Clin Sci. (London), 92, pp. 453-4.
15. Ogawa, H and Suefuji, H and Soejima, H and Nishiyama, K and Misumi, K and Takazoe, K and (2000) Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction Cardiology, 93, pp. 93-9.
16. El-Gendi, H and Violaris, AG and Foale, R and Sharma, HS and Sheridan, DJ. (2002) Endogenous, local, vascular endothelial growth factor production in patients with chronic total coronary artery occlusions: further evidence for its role in angiogenesis Heart, 87, pp. 158-9.
17. Fleisch M, Billinger M, Eberl FR, Garachemani AR, MeierB, Seiler C, Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation. 1999;100:1945-50.
18. Hasegawa, Y and Takanashi, S and Kanehira, Y and Tsushima, T and Imai, T and Okumura, K. (2001) Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma Cancer, 91, pp. 964-71.
19. van Royen, N and Hoefer, I and Buschmann, I. (2002) Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation FASEB J, 16, pp. 432-4.
20. Werner, GS and Jandt, E and Krack, A and Schwarz, G and Mutschke, O and Kuethe, F and (2004-5) Growth factors in the collateral circulation of chronic total coronary occlusions: Relation to duration of occlusion and collateral function Circulation, 110, pp. 1940-5.